⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6404479 | 0.73 | — | — | |
| SCHEMBL9830777 | 0.63 | — | — | |
| SCHEMBL586833 | 0.60 | — | — | |
| SCHEMBL7476994 | 0.58 | — | — | |
| SCHEMBL11187202 | 0.58 | — | — | |
| SCHEMBL8057756 | 0.57 | — | — | |
| SCHEMBL13278139 | 0.56 | — | — | |
| SCHEMBL18871789 | 0.56 | — | — | |
| SCHEMBL8223214 | 0.55 | — | — | |
| SCHEMBL18327710 | 0.52 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1503763-A1 | THERAPEUTIC 1,2,3,6-TETRAHYDROPYRIMIDINE-2-ONE COMPOSITIONS AND METHODS THEREWITH | Cragmont Pharmaceuticals, LLC (US) | 2005-02-09 | — | — | EP | disclosed |
| WO-2003092697-A1 | THERAPEUTIC 1,2,3,6-TETRAHYDROPYRIMIDINE-2-ONE COMPOSITIONS AND METHODS THEREWITH | CRAGMONT PHARMACEUTICALS, LLC (US) | 2003-11-13 | — | — | WO | disclosed |
| US-20030207904-A1 | 1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for pain and inflammation | CRAGMONT PHARMACEUTICALS, LLC | 2003-11-06 | — | — | US | disclosed |
| US-20030207851-A1 | Therapeutic 1,2,3,6-tetrahydropyrimidine-2-one compositions and methods therewith | CRAGMONT PHARMACEUTICALS, LLC | 2003-11-06 | — | — | US | disclosed |
| US-20030206873-A1 | 1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for gastrointestinal dysfunction | CRAGMONT PHARMACEUTICALS, LLC | 2003-11-06 | — | — | US | disclosed |
| US-20030207903-A1 | 1,2,3,6-tetrahydropyrimidine-2-one compositions and therapeutic methods therewith for sexual disfunction | WEI EDWARD T (US) | 2003-11-06 | — | — | US | disclosed |
| US-20030206866-A1 | 1,2,3,6-Tetrahydropyrimidine-2-one compositions, articles and therapeutic methods for upper airway breathing disorders | CRAGMONT PHARMACEUTICALS LLC. | 2003-11-06 | — | — | US | disclosed |